About Us

Interim Management • Financial Consulting • Fiscal Stewardship

About Us/ Core Team Bios

We approach each company holistically, whether as an advisor, an interim executive or liquidating manager/trustee. This enables us to respond creatively and adjust quickly to any unique problem an engagement presents. Every engagement, large or small begins with a specific analytical assessment of the unique facts and metrics of the situation. A prioritized set of action steps is generated immediately thereafter as the first stage of a disciplined process to conserve money and time.... Our people draw on practical experience managing finance, accounting, legal and intellectual property functions. Most importantly, we are objective, candid and dispassionate with our clients determining what a company needs, where it stands and its prospects.

We are keenly focused on preserving or improving stockholder value but understand and appreciate the human component of technology driven organizations and their intellectual property.

Core Team Bios

John Skolas – CEO & Founder

John's experience includes leadership roles in management, financial, legal and intellectual property functions in technology, life sciences and entertainment companies. In addition to management and advisory roles, his work includes a wide range of restructuring activities and demerger transactions, winding down businesses, patent licensing, managing litigation and creative transactions to realize value from unwanted assets. John is currently helping a high profile entrepreneur develop a new business model for drug discovery geared to generate cash and more rapid investor exits from a portfolio of platforms.  He is wrapping up a liquidating trust engagement for a publicly traded biotech company (see the case study on the Fact Sheet page). As an interim manager, his recent engagements include an ongoing role as acting CFO and advisor to a medical imaging start up, an engagement as interim CFO of an internet advertising optimization company for which he secured asset based financing and refocused the firm’s financial metrics, modeling and analysis for an investor considering a factory restart in Australia, economic research and analysis for a major branded pharmaceutical product. From 2003 until 2007, John was CFO and General Counsel of Genaera Corporation a NASDAQ traded biopharmaceutical company. Prior to that, he served as a consultant and acting CFO for early stage companies in life sciences and technology. His earlier full time CFO roles included a venture backed genomics company and a combinatorial chemistry company subsequently acquired by Lexicon Pharmaceuticals. John's work in life sciences began in the late 90s as Chief Financial Officer and General Counsel of Phytoworks, Inc. a plant based biotech company.

For nearly a decade, John served in financial, legal and leadership roles in the multiyear restructuring and demerger of THORN EMI, a multinational conglomerate in more than 60 businesses.  Those transformed the company into EMI Group plc, a recording and music publishing giant. For EMI, John’s work included numerous divestitures, M&A, management of a semiconductor patent licensing program that generated $240 million, management and divestiture of real estate on both coasts, winding down of unsuccessful businesses, closing a range of debt and loan facility transactions and culminating with design and execution of key steps in the $1.5 billion demerger and spin off of EMI’s rental and retail assets. John served in various executive positions for EMI including five years as President and General Counsel of its subsidiary EMI Group Inc. EMI Group Inc. provided treasury, tax, administrative and legal services to EMI’s US subsidiaries and managed major corporate transactions as well as residual assets and liabilities from closed and divested businesses. John’s early career included law practice as a partner in Muchin, Muchin , Bendix & Skolas S.C.and accounting practice as a Tax Specialist for Coopers & Lybrand, CPA.

John has an MBA from Harvard Business School, a JD from the University of Wisconsin and a CPA certificate (not in practice) from the State of Iowa.

Leanne Kelly, CPA - Acting and Interim CFO Roles

Leanne has over 10 years experience in accounting, finance and management with a foundation in public accounting. She has worked in companies in various stages of transition including incubator to operating, multi-operational to consolidated and wind-down settings. Her industry experience includes service, technology, internet advertising optimization and biotechnology and she has worked with public and private companies. Leanne has specific expertise in Securities and Exchange Commission reporting, Sarbanes-Oxley implementation and ongoing execution and GAAP research and application. In controller and CFO roles Leanne’s work included multi-million dollar financings, M&A diligence and support, investor relations and communications strategies for scientific meetings and investor presentations. She also has experience in budgeting, forecasting, modeling and financial analysis, as well as investor and public relations and information technology.

Along with her hands on financial perspective, Leanne is keenly interested in accounting policy and practice. In 2006 she worked with the Biotechnology Industry Organization (BIO) and other biotech executives to advocate for changes to audit standards applicable to small public companies under SOX 404 in advance of promulgation of AS5. Her efforts included organizing a fact finding meeting for two SEC Staff and two Commissioners with a biotech company as well as participating in meetings organized by BIO with SEC representatives and administration officials.

Leanne has previously worked for Genaera Corporation, Lamina Ceramics, Luminant Worldwide Corporation and KPMG LLP. She has a degree in Business and Economics from Lehigh University and is a CPA licensed in the state of Pennsylvania

Jane Bickel - Trust Administrator

Jane has over 20 years of professional experience in corporate, technical and science communications. With a highly proactive approach to administration, business and communications management and public/customer relations Jane has helped companies successfully improve their corporate systems organization as well as market, promote, and sell products, services, and corporate image in both the United States and Canada. Jane's specific industry experience includes biotechnology, pharmaceutical staffing, engineering and construction management and ISO-based manufacturing. She provides each client with a single point-of-contact for all administrative functions related to ARGYCE services.

Jane has a Bachelor of Science degree in Communications from Drexel University in Philadelphia, PA.